deflazacort 6 MG Oral Tablet [Emflaza]
- RxCUI
- 1870950
- RxNorm name
- deflazacort 6 MG Oral Tablet [Emflaza]
- Display name
- deflazacort 6 MG Oral Tablet [Emflaza]
- Full name
- deflazacort 6 MG Oral Tablet [Emflaza]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:52
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| EMFLAZA | DEFLAZACORT | PTC Therapeutics, Inc. | 31b347d2-f156-4055-9d8f-7cf0df420296 | 2025-11-13 | Warnings, Adverse reactions | 1870950 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 31b347d2-f156-4055-9d8f-7cf0df420296 | deflazacort 6 MG Oral Tablet [Emflaza] | SBD | 21 | These highlights do not include all the information needed to use EMFLAZA ® safely and effectively. See full prescribing information for EMFLAZA. EMFLAZA ® (deflazacort) tablets, for oral use EMFLAZA ® (deflazacort) oral suspension Initial U.S. Approval: 2017 | 20251113 |
| 31b347d2-f156-4055-9d8f-7cf0df420296 | Emflaza 6 MG Oral Tablet | PSN | 21 | These highlights do not include all the information needed to use EMFLAZA ® safely and effectively. See full prescribing information for EMFLAZA. EMFLAZA ® (deflazacort) tablets, for oral use EMFLAZA ® (deflazacort) oral suspension Initial U.S. Approval: 2017 | 20251113 |
| 31b347d2-f156-4055-9d8f-7cf0df420296 | Emflaza 6 MG Oral Tablet | SY | 21 | These highlights do not include all the information needed to use EMFLAZA ® safely and effectively. See full prescribing information for EMFLAZA. EMFLAZA ® (deflazacort) tablets, for oral use EMFLAZA ® (deflazacort) oral suspension Initial U.S. Approval: 2017 | 20251113 |